Skip to main content
Premium Trial:

Request an Annual Quote

Sloan-Kettering Institute Licenses GeneBio's Phenyx Software

NEW YORK (GenomeWeb News) – The Sloan-Kettering Institute, part of the Memorial Sloan-Kettering Cancer Center, has licensed Geneva Bioinformatics’ PhenyxServer protein identification and characterization software, GeneBio said today.
 
Under the agreement, Sloan-Kettering researcher Paul Tempst will use the Phenyx protein identification and characterization software in its Clinical Proteomic Technology Assessment for Cancer group.
 
The Phenyx identification and characterization software platform, which was developed through a partnership with the Swiss Institute of Bioinformatics, includes protein searches and comparison and quantitation of multiple results.
 
Financial terms of the agreement were not released.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.